A Phase 1, Randomized, Observer-blind, Placebo-controlled, Age De-escalation Study of the Safety, Tolerability, and Immunogenicity of mRNA-1345 and mRNA-1365 in Participants Aged 5 months to < 24 months

  • Carr, Jeremy (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA/ERM Reference Number: 100516
Monash Health Reference Number: SSA/100516/MonH-2024-417898
Monash Health Reference: RES-24-0000-168X
Effective start/end date21/03/2420/03/29